Ocera Therapeutics (OCRX)
followers
·
Follow
Sector: | HEALTH CARE |
Industry: | PHARMACEUTICALS |
SIC: | PHARMACEUTICAL PREPARATIONS |
CEO: | Linda S. Grais |
Employees: | 19 |
Web site: | www.ocerainc.com |
555 TWIN DOLPHIN DRIVE, SUITE 615, REDWOOD CITY, CA, 94065
6504750158
|
• *** This stock is shown as delisted in our database. *** If you think this isn't correct then please let us know
-
Formally known as:
- TRANZYME INC
Date | Ratio |
---|---|
2013-07-16 | 1:12 |
All 13F Filers | Prior | Change | Hedge Funds 1 | Prior | Change |
---|
Ocera Therapeutics, Inc. is a clinical stage biopharmaceutical company. It engages in development and commercialization of OCR-002 (ornithine phenylacetate0 in intravenous and oral formulations. The company was founded by Wu Xiaoyun, John C. Kappes, and Eckard Weber on January 12, 1998 and is headquartered in Palo Alto, CA.
Please log in first to see chart